Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF ERGOTHIONEINE IN PROMOTING COLLAGEN GENERATION
Document Type and Number:
WIPO Patent Application WO/2024/022318
Kind Code:
A1
Abstract:
The present application provides a collagen generation promoter comprising ergothioneine as an effective component, use of ergothioneine in promoting type III collagen generation, and use of ergothioneine in preparing a product for combating skin aging or preventing or alleviating skin problems related to type III collagen reduction. Ergothioneine has the effect of promoting type III collagen generation. Thus, as a collagen generation promoter, ergothioneine can be widely used for preparing products for promoting type III collagen generation and products for combating skin aging.

Inventors:
LIU SHAOYING (CN)
WANG RUIYAN (CN)
LU ZHEN (CN)
ZHANG YIMING (CN)
ZHANG XIAOOU (CN)
MAO HUA (CN)
TAO WENWEN (CN)
Application Number:
PCT/CN2023/109052
Publication Date:
February 01, 2024
Filing Date:
July 25, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BLOOMAGE BIOTECHNOLOGY CORP LTD (CN)
BEIJING BLOOMAGE HYINGC AND TECH CO LTD (CN)
BLOOMATURE BIOTECHNOLOGY CO LTD (CN)
International Classes:
A23L33/175; A61K31/4172; A61K8/49; A61P17/18; A61Q19/08
Foreign References:
US20020042438A12002-04-11
JP4865083B12012-02-01
Other References:
HSEU YOU-CHENG, VUDHYA GOWRISANKAR YUGANDHAR, CHEN XUAN-ZAO, YANG YI-CHEN, YANG HSIN-LING: "The Antiaging Activity of Ergothioneine in UVA-Irradiated Human Dermal Fibroblasts via the Inhibition of the AP-1 Pathway and the Activation of Nrf2-Mediated Antioxidant Genes", OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, HINDAWI PUBLISHING CORPORATION, US, vol. 2020, 12 February 2020 (2020-02-12), US , pages 1 - 13, XP093133608, ISSN: 1942-0900, DOI: 10.1155/2020/2576823
KO, H.J. ET AL.: "Ergothioneine Alleviates Senescence of Fibroblasts Induced by UVB Damage of Keratinocytes via Activation of the Nrf2/HO-1 Pathway and HSP70 in Keratinocytes.", EXPERIMENTAL CELL RESEARCH, vol. 400, no. 1, 9 February 2021 (2021-02-09), XP086503109, ISSN: 0014-4827, DOI: 10.1016/j.yexcr.2021.112516
Attorney, Agent or Firm:
BEIJING TANGSONG IP FIRM (CN)
Download PDF: